IL131399A0 - The use of aryl-cyclohexylamine derivatives against cns disorders - Google Patents

The use of aryl-cyclohexylamine derivatives against cns disorders

Info

Publication number
IL131399A0
IL131399A0 IL13139999A IL13139999A IL131399A0 IL 131399 A0 IL131399 A0 IL 131399A0 IL 13139999 A IL13139999 A IL 13139999A IL 13139999 A IL13139999 A IL 13139999A IL 131399 A0 IL131399 A0 IL 131399A0
Authority
IL
Israel
Prior art keywords
aryl
cns disorders
derivatives against
against cns
cyclohexylamine derivatives
Prior art date
Application number
IL13139999A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL131399A0 publication Critical patent/IL131399A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
IL13139999A 1998-08-18 1999-08-13 The use of aryl-cyclohexylamine derivatives against cns disorders IL131399A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98115484 1998-08-18

Publications (1)

Publication Number Publication Date
IL131399A0 true IL131399A0 (en) 2001-01-28

Family

ID=8232474

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13139999A IL131399A0 (en) 1998-08-18 1999-08-13 The use of aryl-cyclohexylamine derivatives against cns disorders

Country Status (24)

Country Link
US (1) US6184236B1 (hr)
JP (1) JP3455142B2 (hr)
KR (1) KR100341194B1 (hr)
CN (1) CN1141936C (hr)
AR (1) AR021770A1 (hr)
AT (1) ATE326219T1 (hr)
AU (1) AU756408B2 (hr)
BR (1) BR9903779A (hr)
CA (1) CA2280455A1 (hr)
DE (1) DE69931316D1 (hr)
HR (1) HRP990256A2 (hr)
HU (1) HUP9902737A3 (hr)
ID (1) ID23107A (hr)
IL (1) IL131399A0 (hr)
MA (1) MA26677A1 (hr)
MY (1) MY133133A (hr)
NO (1) NO993948L (hr)
NZ (1) NZ337243A (hr)
PE (1) PE20000955A1 (hr)
PL (1) PL334949A1 (hr)
SG (1) SG82014A1 (hr)
TR (1) TR199902015A2 (hr)
YU (1) YU38699A (hr)
ZA (1) ZA995212B (hr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003535851A (ja) * 2000-06-06 2003-12-02 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 二環式シクロヘキシルアミン類およびそれらのnmda受容体アンタゴニストとしての使用
CA2440284A1 (en) * 2001-03-08 2002-09-19 Emory University Ph-dependent nmda receptor antagonists
DE10153345A1 (de) * 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte 1H-Chinoxalin-2-on-Verbindungen und substituierte 4-Aryl- und 4-Heteroarylcyclohexan-Verbindungen
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
CA2693032A1 (en) * 2007-06-29 2009-01-08 Emory University Nmda receptor antagonists for neuroprotection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4032766A1 (de) 1990-10-16 1992-04-30 Basf Ag Phenylpiperidinoylamine und diese enthaltende arzneimittel
DE4117904A1 (de) 1991-05-31 1992-12-03 Basf Ag Substituierte n-phenylpiperidine
ATE130851T1 (de) 1991-03-14 1995-12-15 Basf Ag Substituierte n-phenylpiperidine und arzneimittel daraus.
CZ126598A3 (cs) * 1995-10-26 1998-09-16 Mitsubishi-Tokyo Pharmaceuticals, Inc. Fenylethanolaminové sloučeniny, způsob jejich výroby a farmaceutické prostředky s jejich obsahem

Also Published As

Publication number Publication date
MY133133A (en) 2007-10-31
AU4453799A (en) 2000-05-04
JP2000109429A (ja) 2000-04-18
ID23107A (id) 2000-02-24
HU9902737D0 (en) 1999-10-28
PL334949A1 (en) 2000-02-28
NZ337243A (en) 2000-12-22
AU756408B2 (en) 2003-01-09
AR021770A1 (es) 2002-08-07
DE69931316D1 (de) 2006-06-22
ATE326219T1 (de) 2006-06-15
HUP9902737A3 (en) 2001-01-29
NO993948L (no) 2000-02-21
NO993948D0 (no) 1999-08-17
HRP990256A2 (en) 2000-04-30
ZA995212B (en) 2000-02-18
CN1248439A (zh) 2000-03-29
HUP9902737A2 (hu) 2000-06-28
CN1141936C (zh) 2004-03-17
US6184236B1 (en) 2001-02-06
CA2280455A1 (en) 2000-02-18
TR199902015A3 (tr) 2000-03-21
JP3455142B2 (ja) 2003-10-14
SG82014A1 (en) 2001-07-24
TR199902015A2 (xx) 2000-03-21
PE20000955A1 (es) 2000-09-28
MA26677A1 (fr) 2004-12-20
YU38699A (sh) 2002-03-18
KR100341194B1 (ko) 2002-06-20
KR20000017343A (ko) 2000-03-25
BR9903779A (pt) 2000-09-19

Similar Documents

Publication Publication Date Title
HUP0104676A3 (en) Compositions for the treatment of anorectal disorders and their use
EP1063990A4 (en) THERAPY FOR ESTROGEN RELATED DISORDERS
ZA9810218B (en) Isoquinoline derivatives for use against cns disorders
HK1053058A1 (zh) 普拉克索用於治療成癮性疾病的用途
ZA200107689B (en) 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders.
HK1039124B (zh) 二氮雜萘衍生物磷酸二酯酶4抑制劑
AU2002215047A1 (en) Isoquinoline derivatives useful in the treatment of cns disorders
AU7388101A (en) Indole derivatives useful for the treatment of cns disorders
HU9902737D0 (en) The use of aryl-cyclohexylamine derivatives against cns disorders
AU8173801A (en) Indole derivatives useful for the treatment of cns disorders
IL153254A0 (en) Indole derivatives useful for the treatment of cns disorders
TW371925U (en) Structure of the caster
GB9816352D0 (en) The treatment of inflammatory disorders
GB9816349D0 (en) The treatment of inflammatory disorders
SI1049672T1 (en) Azetidinecarboxamide derivatives for treating cns disorders
SI1049670T1 (en) Azetidinecarboxamide derivatives for treating cns disorders
TW380671U (en) Improvement of the screw
HK1059086A1 (en) Indole derivatives useful for the treatment of cns disorders
IL153351A0 (en) Indole derivatives useful for the treatment of cns disorders
SI1305307T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1294710T1 (en) Indole derivatives useful for the treatment of cns disorders
GB9824713D0 (en) Cognitive disorders
GB9824711D0 (en) Cognitive disorders
TW378743U (en) Preheating box of the shower
GB9816355D0 (en) The treatment of viral disorders